Welcome to LookChem.com Sign In|Join Free

CAS

  • or
4-Oxazolecarboxylic acid, 4,5-dihydro-5-(1-methylethyl)-2-phenyl-, methyl ester, (4R,5S)- is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

148906-20-1 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 148906-20-1 Structure
  • Basic information

    1. Product Name: 4-Oxazolecarboxylic acid, 4,5-dihydro-5-(1-methylethyl)-2-phenyl-, methyl ester, (4R,5S)-
    2. Synonyms:
    3. CAS NO:148906-20-1
    4. Molecular Formula: C14H17NO3
    5. Molecular Weight: 247.294
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 148906-20-1.mol
  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: N/A
    3. Flash Point: N/A
    4. Appearance: N/A
    5. Density: N/A
    6. Refractive Index: N/A
    7. Storage Temp.: N/A
    8. Solubility: N/A
    9. CAS DataBase Reference: 4-Oxazolecarboxylic acid, 4,5-dihydro-5-(1-methylethyl)-2-phenyl-, methyl ester, (4R,5S)-(CAS DataBase Reference)
    10. NIST Chemistry Reference: 4-Oxazolecarboxylic acid, 4,5-dihydro-5-(1-methylethyl)-2-phenyl-, methyl ester, (4R,5S)-(148906-20-1)
    11. EPA Substance Registry System: 4-Oxazolecarboxylic acid, 4,5-dihydro-5-(1-methylethyl)-2-phenyl-, methyl ester, (4R,5S)-(148906-20-1)
  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 148906-20-1(Hazardous Substances Data)

148906-20-1 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 148906-20-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,4,8,9,0 and 6 respectively; the second part has 2 digits, 2 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 148906-20:
(8*1)+(7*4)+(6*8)+(5*9)+(4*0)+(3*6)+(2*2)+(1*0)=151
151 % 10 = 1
So 148906-20-1 is a valid CAS Registry Number.

148906-20-1SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 16, 2017

Revision Date: Aug 16, 2017

1.Identification

1.1 GHS Product identifier

Product name (4R,5S)-5-isopropyl-2-phenyl-4,5-dihydrooxazole-4-carboxylic acid methyl ester

1.2 Other means of identification

Product number -
Other names (4R,5S)-5-Isopropyl-2-phenyl-4,5-dihydro-oxazole-4-carboxylic acid methyl ester

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:148906-20-1 SDS

148906-20-1Downstream Products

148906-20-1Relevant articles and documents

Stereoselective intramolecular cyclization of isopentenyl benzamide via π-allylpalladium complex catalyzed by Pd(0)

Joo, Jae-Eun,Mu, Yu,Lee, Yiu-Suk,Tian, Yong-Shou,Lee, Gyu-Jin,Ham, Won-Hun

experimental part, p. 293 - 304 (2010/08/20)

An efficient procedure was developed to synthesize oxazoline as key intermediate in the total synthesis of (+)-lactacystin using palladium(0)-catalyzed intramolecular cyclization of isopentenyl benzamide via a π-allylpalladium complex. A convenient and ef

Diastereo- And enantioselective synthesis of β-Hydroxy-α-amino acids: Application to the synthesis of a key intermediate for lactacystin

Li, Qiong,Yang, Shao-Bo,Zhang, Zhihui,Li, Lei,Xu, Peng-Fei

supporting information; experimental part, p. 1627 - 1631 (2009/09/24)

The development of a highly efficient and stereoselective methodology for the preparation of β-hydroxy-α- amino acids is described. Nucleophilic addition of enolates of tricyclic iminolactones 1a and 1b to aldehydes in the presence of 6 equiv of lithium chloride in THF at -78 °C leads to aldol adducts in good yield (63-86%) and high diastereoselectivity (up to >25:1 dr). Subsequently, hydrolysis of the aldol adducts under acidic conditions leads to the corresponding β-hydroxy-a-amino acids in good yields (up to 83%) and excellent enantiomeric excesses (99% ee) with good recovery yields of the chiral auxiliaries 6 and 7. This methodology was applied to the facile synthesis of the key intermediate for lactacystin along with several isomers.

Cytotoxic agents and methods of use

-

Page/Page column 22, (2010/02/14)

Disclosed are compounds that inhibit proteasomic activity in cells. Also disclosed are pharmaceutical compositions comprising such compounds as well as methods to treat conditions, particularly cell proliferative conditions, such as cancer and inflammator

A short, stereocontrolled, and practical synthesis of α-methylomuralide, a potent inhibitor of proteasome function

Saravanan,Corey

, p. 2760 - 2764 (2007/10/03)

An efficient and practical synthesis of α-methylomuralide (3), a selective inhibitor of proteasomes, has been developed as outlined in Scheme 1. Among the advantages of this route of synthesis over previously described approaches are (1) ease of scale-up

A novel and efficient synthesis of a highly active analogue of clasto-lactacystin β-lactone

Soucy, Francois,Grenier, Louis,Behnke, Mark L.,Destree, Antonia T.,McCormack, Teresa A.,Adams, Julian,Plamondon, Louis

, p. 9967 - 9976 (2007/10/03)

Herein, we describe a new convergent synthesis of a more potent analogue of clasto-lactacystin β-lactone (2), PS-519 compound 4, which is currently in preclinical development for the treatment of ischemia-reperfusion injury in stroke and myocardial infarction. The synthetic strategy relies on building two intermediates (an oxazoline and an aldehyde) which are joined through a doubly diastereoselective aldol reaction, setting up the requisite unichiral centers in the final product (4). The facial selectivity and ultimate stereocontrol are achieved by employing a trivalent aluminum Lewis acid, Me2AlCl, in a chelation-induced reaction which yields a single aldol adduct. The efficiency of the synthetic approach has allowed for the preparation of multigram quantities of clinical grade material, which will support Phase I studies.

Total synthesis of (+)-lactacystin

Panek, James S.,Masse, Craig E.

, p. 1093 - 1095 (2007/10/03)

A double stereodifferentiating crotylation between aldehyde 1 and silane (S)-2 to afford homoallylic alcohol 3 is the key diastereoselective step (anti:syn > 30:1) in an efficient asymmetric synthesis of (+)-lactacystin. This compound is a metabolite isol

Total synthesis of (+)-lactacystin

Nagamitsu, Tohru,Sunazuka, Toshiaki,Tanaka, Haruo,Omura, Satoshi,Sprengeler, Paul A.,Smith III, Amos B.

, p. 3584 - 3590 (2007/10/03)

A total synthesis of the novel neurotrophic agent (+)-lactacystin (1) has been achieved in 11 steps and 14% overall yield from (2R,3S)-3-hydroxyleucine [(+)-16]. The construction and bioassay of several active analogs are also described. A new asymmetric approach furnished the four stereoisomers of 3-hydroxyleucine, as required starting materials in high overall yield and enantiomeric purity.

An enantioselective synthesis of (6R)-lactacystin

Corey,Choi, Soongyu

, p. 6969 - 6972 (2007/10/02)

The first enantiospecific, stereocontrolled total synthesis of (6R)-lactacystin, a potential neurotrophic agent, is described.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 148906-20-1